Veterinary Medicines

AviPro IBD Xtreme Lyophilisate for suspension

Authorised
  • Infectious bursal disease virus, strain V217, Live
Download as PDF

Product identification

Medicine name:
AviPro IBD Xtreme Lyophilisate for suspension
AviPro IBD Xtreme
Active substance:
  • Infectious bursal disease virus, strain V217, Live
Target species:
  • Chicken
Route of administration:
  • Intraocular use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain V217, Live
    1000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for use in drinking water
Withdrawal period by route of administration:
  • Intraocular use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • (ID9): 1 Box with 10 Bottle (Glass) with 5000 Dose (50000 Dose)
  • (ID5): 1 Box with 1 Bottle (Glass) with 10000 Dose (10000 Dose)
  • (ID10): 1 Box with 10 Bottle (Glass) with 10000 Dose (100000 Dose)
  • (ID2): 1 Box with 1 Bottle (Glass) with 1000 Dose (1000 Dose)
  • (ID8): 1 Box with 10 Bottle (Glass) with 2500 Dose (25000 Dose)
  • (ID1): 1 Box with 1 Bottle (Glass) with 500 Dose (500 Dose)
  • (ID6): 1 Box with 10 Bottle (Glass) with 500 Dose (5000 Dose)
  • (ID4): 1 Box with 1 Bottle (Glass) with 5000 Dose (5000 Dose)
  • (ID7): 1 Box with 10 Bottle (Glass) with 1000 Dose (10000 Dose)
  • (ID3): 1 Box with 1 Bottle (Glass) with 2500 Dose (2500 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lohmann Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Animal Health GmbH & Co. KG
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.03418.01.1
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0238/001
Concerned member states:
  • Cyprus
  • Greece
  • Hungary
  • Italy
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 7/11/2023
Updated on: 8/11/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."